EUA
Ambry COVID-19 RT-PCR Test
FDA Emergency Use Authorization · Ambry Genetics Laboratory · Jul 16, 2021
Key facts
| Product | Ambry COVID-19 RT-PCR Test |
|---|---|
| Company | Ambry Genetics Laboratory |
| Product type | Real-time RT-PCR, Home Collection, Saliva, Multiple Targets |
| Date | Jul 16, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: